cVNT |
CPE |
|
-
•
BSL-3, low throughput, time-consuming, high condition requirements, and is influenced by subjective explanations from researchers, resulting in cumbersome steps [76,122].
|
PRNT |
Recombinant live virus |
-
•
Reduced time consumption, dynamic monitoring, and objective results [70].
-
•
Can be safely used at BSL-2 laboratories [84,85].
|
|
pVNT |
HIV system |
-
•
BSL-2, high throughput, less time-consuming, specific, sensitive, consistent with live virus results, accurately measure the neutralizing ability of antibodies [66];
-
•
Lentiviral vector-based pseudoviruses differ from conventional retroviral vectors in that they have the ability to infect both dividing and non-dividing cells;
-
•
VSV systems are suitable for neutralizing antibody analysis or screening of high-content therapies [123].
|
-
•
The number of envelope proteins in pseudoviruses is not directly proportional to the copy number of the core genome. The titer needs to be measured through qPCR and other methods, which loses its authenticity, especially when comparing the impact of different mutant S proteins on viral infectivity [105];
-
•
VSV residue in the VSV system may lead to false positive results [111];
-
•
Comparison and validation with live viruses are required.
|
VSV system |
MLV system |
sVNT |
ELISA |
-
•
Cell-independent, safe; high throughput, low cost, less time-consuming [119]; can be used for screening for neutralizing antibodies in the population to investigate the efficacy of protective immunity and vaccination [124].
|
|